For example, while GLO1 is overexpressed in breast carcinomas, colon adenocarcinomas, and head and neck squamous cell carcinomas, its expression level is lower in kidney clear cell carcinoma, kidney papillary cell carcinoma, and cholangiocarcinoma relative to the corresponding normal tissue (Figure S1). The gene discussed is GLO1; the disease is cholangiocarcinoma.